French study examines Real-World results for new mesothelioma treatment

NCT ID NCT05308966

Completed Disease control Sponsor: Groupe Francais De Pneumo-Cancerologie Source: ClinicalTrials.gov ↗

Summary

This study looked back at medical records to see how well a combination of two immunotherapy drugs (nivolumab and ipilimumab) worked for patients with advanced, inoperable pleural mesothelioma. It involved 204 French patients who received the drugs through a special early access program before they were widely available. The goal was to confirm the treatment's benefits and safety in a real-world setting outside of a controlled clinical trial.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CAC Mougins

Mougins, 06250, France
CH Albi

Albi, 81013, France
CH Annecy Genevois

Pringy, 74374, France
CH Argenteuil

Argenteuil, 95010, France
CH Avignon

Avignon, 84000, France
CH Bastia

Bastia, 20200, France
CH Bayonne

Bayonne, 64100, France
CH Bligny

Bligny, 91640, France
CH Cannes

Cannes, 06400, France
CH Cornouaille

Quimper, 02900, France
CH Dijon Bourgogne

Dijon, 21000, France
CH Eure-Seine

Évreux, 27015, France
CH Libourne

Libourne, 33500, France
CH Nevers

Nevers, 58000, France
CH St Quentin

Saint-Quentin, 02321, France
CH Villefranche

Villefranche-sur-Saône, 69400, France
CH Villeurbanne

Villeurbanne, 69100, France
CH de Longjumeau

Longjumeau, 91160, France
CH de Saint Malo

St-Malo, 35400, France
CH du Cotentin

Cherbourg, 50102, France
CH du Mans

Le Mans, 72000, France
CHD les Oudaries

La Roche-sur-Yon, 85000, France
CHITS Toulon Sainte Musse

Toulon, 83056, France
CHRU Bretonneau

Tours, 37044, France
CHU Angers

Angers, 49033, France
CHU Besançon

Besançon, 25000, France
CHU Caen

Caen, 14033, France
CHU Hôpital Montpied

Clermont-Ferrand, 63000, France
CHU La Mileterie

Poitiers, 86021, France
CHU Lille

Lille, 59000, France
CHU Morvan

Brest, 29200, France
CHU Ponchailloux

Rennes, 35000, France
CHU du Pays d'Aix

Aix-en-Provence, 13616, France
Centre Antoine Lacassagne

Nice, 06149, France
Centre Léon Bérard

Lyon, 69373, France
Clinique Ambroise Paré

Beuvry, 63660, France
Clinique Bordeaux

Bordeaux, 33000, France
Clinique Gentilly

Gentilly, 94250, France
Clinique Pasteur

Brest, 29200, France
Clinique Saint Georges

Nice, 06000, France
Clinique Saint Grégoire

Rennes, 35000, France
Clinique de l'Estuaire

Saint-Nazaire, 44600, France
GH Le Havre

Le Havre, 76083, France
GH Paris Site St Joseph

Paris, 75674, France
HIA Begin

Saint-Mandé, 94160, France
HIA St Anne

Toulon, 83800, France
Hôpital Ambroise Paré

Boulogne-Billancourt, 92100, France
Hôpital Bichat

Paris, 75018, France
Hôpital Charles Nicolle

Rouen, 76031, France
Hôpital Cochin

Paris, 75014, France
Hôpital Haut-Lévèque - Groupe Hospitalier SUD

Pessac, 33604, France
Hôpital La Pitié-Salpêtrière

Paris, 75651, France
Hôpital Larrey

Toulouse, 31059, France
Hôpital Louis Pasteur

Colmar, 68000, France
Hôpital Louis Pradel

Bron, 69500, France
Hôpital Nord

Marseille, 13915, France
Hôpital du Scorff

Lorient, 56100, France
Hôpital privé de la Loire

Saint-Etienne, 42100, France
IPC

Marseille, 13009, France
Insititut de Cancerologie de l'Ouest

Saint-Herblain, 44805, France
Institut Curie

Paris, 75005, France
Les Hôpitaux Universitaires de Strasbourg

Strasbourg, 76091, France
Unicancer

Clermont-Ferrand, 63000, France

Conditions

Explore the condition pages connected to this study.

MALIGNANT PLEURAL MESOTHELIOMA UNRESECTABLE MALIGNANT NEOPLASM